SSB
IONS icon

Sandy Spring Bank’s Ionis Pharmaceuticals IONS Stock Holding History

Sandy Spring Bank’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-34
Closed -$1.27K – 1209
2024
Q3 		$1.36K Hold
34
– – ﹤0.01% 1065
2024
Q2 		$1.62K Hold
34
– – ﹤0.01% 1115
2024
Q1 		$1.47K Buy
+34
New +$1.62K ﹤0.01% 1076
2018
Q2 		– Sell
-107
Closed -$5K – 794
2018
Q1 		$5K Hold
107
– – ﹤0.01% 754
2017
Q4 		$5K Buy
+107
New +$5.87K ﹤0.01% 761

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Sandy Spring Bank's IONS Position: Q4 2024 in Review

Sandy Spring Bank sold out of Ionis Pharmaceuticals (IONS) in Q4 2024, closing a stake of 34 shares — an estimated $1.27K sold.

Sandy Spring Bank first reported a position in IONS in Q4 2017 and held it in 5 quarters. The position peaked at $5K in Q1 2018. 355 funds tracked by Wall St. Rank hold IONS as of Q4 2024.

  • Sandy Spring Bank reported no remaining Ionis Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Sandy Spring Bank sold 34 Ionis Pharmaceuticals shares in Q4 2024, an estimated $1.27K.
  • Sandy Spring Bank first reported a position in Ionis Pharmaceuticals in Q4 2017 and held it in 5 quarters.
  • Sandy Spring Bank's Ionis Pharmaceuticals position peaked at $5K in Q1 2018.
  • 355 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2024.

Based on Sandy Spring Bank's 13F filing for Q4 2024, filed 11 Feb 2025.